107 filings
Page 3 of 6
6-K
wkoupy
17 Aug 22
Current report (foreign)
4:18pm
6-K
zbc4zg69gsj9
20 Jul 22
First Half Trading Update
7:46am
6-K
413upw5ag06x
18 May 22
Result of Annual General Meeting
12:03pm
20-F/A
nrxvpk
8 Apr 22
Annual report (foreign) (amended)
7:02am
S-8
p6yq sg50kar1s0
29 Mar 22
Registration of securities for employees
4:34pm
F-3ASR
jion0u3w o9
29 Mar 22
Automatic shelf registration (foreign)
4:30pm
6-K
89qx8pl52a4si6n cc6
17 Mar 22
Current report (foreign)
11:03am
6-K
pg2l5v fys003y
14 Mar 22
Results for the 12- and 18-month periods ended 31 December 2021
8:15am
6-K
3n31hz4iq3zq9p
28 Feb 22
Current report (foreign)
9:25am
6-K
x53at3zo7e a1fh46
27 Jan 22
Current report (foreign)
7:00am
6-K
m9bx797fx759
3 Dec 21
Update on 2021 General Meeting Resolution Vote
2:22pm
6-K
2upqslfeq8uuj9ihp6
12 Nov 21
Current report (foreign)
6:32am
6-K
bq6pxk
27 Oct 21
Abcam Completes Acquisition of BioVision
6:15am
6-K
25fhx 7370nj2
13 Sep 21
29% Constant Currency Revenue Growth in H2 as Lab Activity Gradually Recovers and Demand for Abcam In-house Products Increases
7:01am
6-K
fbau02g
1 Sep 21
Filing of Transition Report on Form 20-F and Notice of Results
7:29am
20-F
fl0k 4qhf
1 Sep 21
Annual report (foreign)
7:26am
6-K
f2n5aaedc 6a91il1
13 Aug 21
Appointment of Non-Executive Director
6:10am
6-K
pihjnw5m1lgj0
2 Aug 21
Abcam to Acquire BioVision for $340 million
6:12am
S-8
18ya up2j
14 Jul 21
Registration of securities for employees
4:02pm